- Current report filing (8-K)
22 2월 2012 - 2:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act 1934
Date of Report (date of earliest event reported):
February 21, 2012
American Oriental Bioengineering, Inc.
(Exact name of registrant as specified in charter)
Nevada
(State or other jurisdiction of incorporation)
001-32569
|
|
84-0605867
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
1 Liangshuihe First Ave, Beijing E-Town Economic
and Technology Development Area, E-Town,
Beijing, 100176, People’s Republic
of China
(Address of principal executive offices and
zip code)
86-10-5982-2039
(Registrant’s telephone number including
area code)
(Registrant’s former name or former address,
if changed since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
[_]
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_]
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_]
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_]
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On February 21, 2012, American Oriental Bioengineering,
Inc. (the “Company”) issued a press release announcing its Board of Directors has adopted resolutions approving a reverse
stock split of the Company’s outstanding shares of common stock. A copy of the press release is attached hereto as Exhibit
99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
|
Description
|
99.1
|
Press Release dated February 21, 2012
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AMERICAN ORIENTAL BIOENGINEERING, INC.
|
|
|
|
By:
|
/s/ Tony Liu
|
|
|
Name: Tony Liu
Title: Chairman and Chief Executive Officer
|
Dated:
February 21, 2012
Exhibit Index
Exhibit No.
|
Description
|
99.1
|
Press Release dated February 21, 2012
|
American Oriental Bioengineering, Inc. (NYSE:AOB)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
American Oriental Bioengineering, Inc. (NYSE:AOB)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024